2 results
Approved WMOCompleted
Efficacy and safety trial with S 44819 after recent ischemic cerebral Event
Approved WMOCompleted
Objective: To demonstrate the non-inferiority of ertugliflozin compared with anon-ertugliflozin comparator group on the time to first occurrence of any of thecomponents of the composite endpoint of cardiovascular death, non-fatal…